Ad hoc Committee of the Croatian Society for Neurovascular Disorders, Croatian Medical Association: Recommendations for neuropathic pain treatment

Acta Clinica Croatica

Volumn 47, Issue 3, 2008, Pages 181-191

  Demarin, Vida ^a   Bašić Kes, Vanja ^a   Zavoreo, Iris ^a   Bosnar Puretić, Marijana ^a   Rotim, Krešimir ^a   Lupret, Velimir ^a   Perić, Mladen ^a   Ivanec, Željko ^a   Fumić, Lidija ^a   Lušić, Ivo ^b   Aleksić Shihabi, Anka ^c   Kovač, Biserka ^d   Ivanković, Mira ^e   Škobić, Helena ^f   Maslov, Boris ^f   Bornstein, Natan ^g   Niederkorn, Kurt ^h   Sinanović, Osman ⁱ   Rundek, Tanja ^j  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

^c Sibenik General Hospital   (Croatia)

^d Vukovar General Hospital   (Croatia)

^e Dubrovnik General Hospital   (Croatia)

^f UNIVERSITY OF MOSTAR   (Bosnia and Herzegovina)

^g TEL AVIV UNIVERSITY   (Israel)

^h UNIVERSITY HOSPITAL GRAZ   (Austria)

ⁱ University Department of Neurology   (Bosnia and Herzegovina)

^j UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Guideline; Neuralgia etiology; Neuralgia physiopathology; Neuralgia therapy; Pain therapy; Practice guideline

Indexed keywords

AMITRIPTYLINE; BUPRENORPHINE; CANNABINOID; CAPSAICIN; CARBAMAZEPINE; CISPLATIN; CORTICOSTEROID; DULOXETINE; FENTANYL; GABAPENTIN; HYDRALAZINE; ISONIAZID; LAMOTRIGINE; LIDOCAINE; METHADONE; MORPHINE; NITROFURANTOIN; OXCARBAZEPINE; OXYCODONE; PHENYTOIN; PREGABALIN; TAXANE DERIVATIVE; THALIDOMIDE; TOPIRAMATE; TRAMADOL; TRICARBOXYLIC ACID; VALPROIC ACID; VENLAFAXINE; VINCRISTINE;

ACUPUNCTURE; AMPUTATION; AMYLOIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; ANALGESIA; BORRELIA INFECTION; BURNING SENSATION; CARPAL TUNNEL SYNDROME; CEREBROVASCULAR ACCIDENT; CERVICOBRACHIAL NEURALGIA; COGNITIVE DEFECT; COMPLEX REGIONAL PAIN SYNDROME; CONSTIPATION; CRYOGLOBULINEMIA; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE COURSE; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MEGADOSE; ELECTROSTIMULATION; EOSINOPHILIA MYALGIA SYNDROME; EPILEPSY; EPSTEIN BARR VIRUS; ERYTHEMA; FABRY DISEASE; FATIGUE; FEEDBACK SYSTEM; GAIT DISORDER; GLOSSOPHARYNGEAL NEURALGIA; GLUE SNIFFING; GUILLAIN BARRE SYNDROME; HEADACHE; HEART PALPITATION; HEPATITIS; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPONATREMIA; HYPOTHYROIDISM; IONTOPHORESIS; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; LUPUS ERYTHEMATOSUS; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NEUROPATHY; MULTIPLE SCLEROSIS; NAUSEA; NERVOUS SYSTEM INJURY; NEUROPATHIC PAIN; NOCICEPTION; ORTHOSTATIC HYPOTENSION; PAIN; PAIN ASSESSMENT; PARANEOPLASTIC SYNDROME; PERIPHERAL EDEMA; PORPHYRIA; POSTHERPETIC NEURALGIA; RELAXATION TRAINING; REVIEW; RISK FACTOR; SEDATION; SENSITIZATION; SENSORY NEUROPATHY; SIDE EFFECT; SOMATOSENSORY CORTEX; SOMNOLENCE; SPINAL CORD INJURY; SUICIDE; SYMPATHETIC BLOCKING; TRANSCUTANEOUS NERVE STIMULATION; TRIGEMINUS NEURALGIA; ULTRASOUND THERAPY; UNSPECIFIED SIDE EFFECT; UREMIA; URINARY DYSFUNCTION; URINARY HESITATION; VITAMIN DEFICIENCY; VOMITING; XEROSTOMIA; ARTICLE; NEURALGIA; PRACTICE GUIDELINE;

ACUPUNCTURE THERAPY; HUMANS; NEURALGIA; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 58149397892     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. MERSKEY H, BOGDUK N. Classification of chronic pain. Seattle: IASP Press, 1994.
2. FINNERUP NB, OTTO M, McQUAY HJ. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289-305.
3. BAŠIĆ-KES V, DEMARIN V. Recommendations for treatment of neuropathic pain. Acta Med Croat 2008;62:237-40.
4. WOOLF CJ, MAX MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology 2001;95:241-9.
5. ATTAL N. Chronic neuropathic pain: mechanisms and treatment. Clin J Pain 2000;16(Suppl 3):S118-S130.
6. HANSSON P. Difficulties in stratifying neuropathic pain by mechanisms. Eur J Pain 2003;7:353-7.
7. JENSEN TS, BARON R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003;102:1-8.
8. DUBINSKY RM, KABBANI H, El-CHAMI Z. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959-65.
9. ATTAL N, CRUCCU G, HAANPAA M, HANSSON P. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2006;13:1153-69.
10. BRAININ M, BARNES M, BARON JC. Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations. Eur J Neurol 2004;11:577-81.
11. RASMUSSEN PV, SINDRUP SH, JENSEN TS. Symptoms and signs in patients with suspected neuropathic pain. Pain 2004;110:461-9.
12. FINNERUP NB, OTTO M, JENSEN TS, SINDRUP SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289-305.
13. ADRIAENSEN H, PLAGHKI L, MATHIEU C. Critical review of oral drug treatments for diabetic neuropathic pain - clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies. Diabet Metab Res Rev 2005;21:231-40.
14. HEMPENSTALL K, NURMIKKO TJ, JOHNSON RW et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Medicine 2005;2:628-44.
15. SAARTO T, WIFFEN P. Antidepressants for neuropathic pain. Cochrane Database of Systemic Reviews 2005; 20a: CD005454.
16. SINDRUP SH, OTTO M, FINNERUP NB. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Ther 2005;96:399-409.
17. WIFFEN P, McQUAY H, EDWARDS J. Gabapentin for acute and chronic pain. Cochrane Database Systematic Reviews 2005; 20: CD005452.
18. WIFFEN P, McQUAY H, MOORE R. Carbamazepin for acute and chronic pain. Cochrane Database Systematic Reviews 2005b; 20: CD005451.
19. WIFFEN P, COLLINS S, McQUAY H. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Systematic Reviews 2005c; 20: CD001133.
20. STANDISH Lj, KOZAK L, CONGDON S. Acupuncture is underutilized in hospice and palliative medicine. Am J Hosp Palliat Care 2008 (Epub ahead of print).
21. LEWITH J, FIELD J. Acupuncture compared with placebo in postherpetic neuralgia. Pain 1983;17:361-8.
22. SPACER A, KRESS HG. Acupuncture in symptomatic reflex dysthrophy? Pain 1997;11:20-3.
23. CAUTHEN JC, RENNER EJ. Transcutaneous and peripheral nerve stimulation for chronic pain states. Surg Neurol 1975;4:102-4.
24. MEYLER WJ, de JONGSTE MJL, ROLF CAM. Clinical evaluation of pain treatment with electrostimulation: a study of TENS in patients with different pain syndromes. Clin J Pain 1994;10:22-7.
25. SOMERS DL, CLEMENTE R. TENS for the management of neuropathic pain. Phys Ther 2006;86:698-706.
26. CHESTERTON LS, FOSTER NE, WRIGHT CC. Effects of TENS frequency, intensity and stimulation site parameter manipulation on pressure pain thresholds in healthy human subjects. Pain 2003;106:73-80.
27. OTTO M, BAK S, BACH FW. Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain 2003;101:187-92.
28. SINDRUP SH, JENSEN TS. Phaimacologic treatment of pain in polyneuropathy. Neurology 2000;55:915-20.
29. VRETHEM M, BOIVIE J, ARNQVIST H. A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997;13:313-23.
30. SINDRUP SH, GRAM LF, SKJOLD T. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990;30:683-91.
31. ROWBOTHAM MC, GOLI V, KUNZ NR. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004;110:697-706.
32. SINDRUP SH, BACH FW, MADSEN C. Venlafaxine versus imipramine in painful polyneuropathy. A randomized, controlled trial. Neurology 2003;60:1284-9.
33. GOLDSTEIN DJ, LU Y, DETKE MJ. Duloxetine versus placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-18.
34. RASKIN J, PRITCHETT YL, WANG F. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-56.
35. WERNICKE JF, PRITCHETT YL, D'SOUZA DN, WANINGER A, TRAN P. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006;67:1411-20.
36. RULL JA, QUIBRERA R, GONZALEZ-MILLAN H. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969;5:215-8.
37. WILTON TD. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974;48:869-72.
38. GOMEZ-PEREZ FJ, CHOZA R, RIOS JM. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 1996;27:525-9.
39. DOGRA S, BEYDOUN S, MAZZOLA J. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo controlled study. Eur J Pain 2005;9:543-54.
40. EISENBERG E, LURIE Y, BRAKER C. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57:505-9.
41. THIENEL U, NETO W, SCHWABE SK, et al. Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 2004;110:221-31.
42. RASKIN P, DONOFRIO PD, ROSENTHAL NR. Topiramate vs placebo in painful diabetic polyneuropathy: analgesic and metabolic effects. Neurology 2004;63:865-73.
43. KOCHAR DK, JAIN N, AGARWAL RP. Sodium valproate in the management of painful polyneuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand 2002;106:248-52.
44. KOCHAR DK, RAWAT N, AGRAWAL RP. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. Q J Med 2004;97:33-8.
45. OTTO M, BACH FW, JENSEN TS. Valproic acid has no effect on pain in polyneuropathy: a randomized controlled trial. Neurology 2004;62:285-8.
46. BACKONJA M, BEYDOUN A, EDWARDS KR. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831-6.
47. DOOLEY DJ, DONOVAN CM, MEDER WP. Preferential action of gabapentin and pregabalin at P/Q voltage-sensitive calcium channels: inhibition of K+ evoked /3H/-norepinephrine release from rat neocortical slices. Synapse 2002;45:171-90.
48. NICHOLSON B. Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 2000;101:359-71.
49. LESSER H, SHARMA U, LaMOREAUX L. Pregabalin relieves symptoms of painful diabetic neuropathy. Neurology 2004;63:2104-10.
50. ROSENSTOCK J, TUCHMANN M, LaMOREAUX L. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004;110:628-38.
51. SIMPSON DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis 2001;3:53-62.
52. RICHTER RW, PORTENOY R, SHARMA U. Relief of diabetic peripheral neuropathy with pregabalin: a randomized placebo-controlled trial. J Pain 2005;6:253-60.
53. FREYNHAGEN R, STROJEK K, GRIESING T. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005;115:254-63.
54. MORELLO CM, LECKBAND SG, STONER CP. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-7.
55. WATSON CP, MOULIN D, WATT-WATSON J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8.
56. GIMBEL JS, RICHRDS P, PORTENOY RK. Controlled-release oxycodone for pain in diabetic neuropathy. A randomized controlled trial. Neurology 2003;60:927-34.
57. DWORKIN RH, O'CONNOR AB, BACKONJA M, FARRAR JT, FINNERUP NB, JENSEN TS. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51.
58. SINDRUP SH, ANDERSEN G, MADSEN C. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999;83:85-90.
59. SANG CN, BOOHER S, GILRON I. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia. Efficacy and dose-response trials. Anesthesiology 2002;96:1053-61.
60. NELSON KA, PARK KM, ROBINOVITZ E. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48:1212-8.
61. ERTAS M, SAGDUYU A, ARAC N. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 1998;75:257-9.
62. SIMPSON DM, OLNEY R, McARTHUR JC. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000;54:2115-9.
63. SIMPSON DM, McARTHUR JC, OLNEY R. Lamotrigine for HIV-associated painful sensoty neuropathies: a placebo-controlled trial. Neurology 2003;60:1508-14.
64. HAHN K, ARENDT G, BRAUN JS. German Neuro-AIDS Working Group. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neutol 2004;251:1260-6.
65. SHLAY JC, CHALONER K, MAX MB. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1998;280:1590-5.
66. KIEBURTZ K, SIMPSON D, YIANNOUTSOS C. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Protocol Team. Neurology 1998;242:1682-8.
67. ESTANISLAO L, CARTER K, McARTHUR J. The Lidoderm-HIV Neuropathy Group. EFNS Eur J Neurol 2006;13:1153-69.
68. KEMPER CA, KENT G, BURTON S, DERESINSKI SC. Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:367-72.
69. PAICE JA, FERRANS CE, LASHLEY FR. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manag 2000;19:45-52.
70. HAMMACK JE, MICHALAK JC, LOPRINZI CL. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 2002;98:195-203.
71. GILRON I, BAILEY JM, TU D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-34.
72. NURMIKKO T, BOWSHER D. Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 1990;53:135-41.
73. WATSON CP, CHIPMAN M, REED K, et al. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992;48:29-36.
74. WATSON CP, VERNICH L, CHIPMAN M. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51:1166-71.
75. ROWBOTHAM MC, HARDEN N, STACEY B. Gabapentin for treatment of postherpetic neuralgia. JAMA 1998;280:1837-43.
76. RICE ASC, MATON S, Post Herpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia; a randomised, double-blind, controlled study. Pain 2001;94:15-24.
77. DWORKIN RH, CORBIN AE, YOUNG JP Jr. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003b;60:1274-83.
78. SABATOWSKI R, GALVEZ R, CHERRY DA. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004;109:26-35.
79. KOCHAR DK, GARG P, BUMB RA. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. Q J Med 2005;98:29-34.
80. GALER BS, ROWBOTHAM MC, PERANDER J. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533-8.
81. GALER BS, JENSEN MP, MA T. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002;5:297-301.
82. WASNER G, KLEINERT A, BINDER A, et al. Postherpetic neuralgia: topical lidocaine is effective in nociceptor deprived skin. J Neurol 2005;252:677-86.
83. MEIER T, WASNER G, FAUST M. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo controlled study. Pain 2003;106:151-8.
84. BERNSTEIN JE, KORMAN NJ, BICKERS DR. Topical capsaicin treatment of chronic postherpetic neuralgia. J An Acad Dermatol 1989;21:265-70.
85. WATSON CP, TYLER KL, BICKERS DR. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993;15:510-26.
86. WATSON CP, BABUL N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-41.
87. CHONG MS, HESTER J. Diabetic painful neuropathy. Current and future treatment options. Drugs 2007;67:569-85.
88. HARATY Y, GOOCH C, SWENSON M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-6.
89. FOLEY KM. Opioids and chronic neuropathic pain. N Engl J Med 2003;348:1279-82.
90. EISENBERG E, McNICOL ED, CARR DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pin of nonmalignant origin. JAMA 2005;293:3043-8.
91. ROWBOTHAM MC, TWILLING L, DAVIES PS. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003;348:1223-32.
92. BOUREAU F, LEGALLICIER P, KABIR-AHMADI M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003;104:323-31.
93. EISENBERG E, KLEISER A, DORTORT A. The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double blind, placebo-controlled study. Eur J Pain 1998;2:321-7.
94. MAX MB, SCHÄFER SC, CULNANE M. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427-32.
95. CRUCCU G, TRUINI A. Trigeminal neuralgia and orofacial pains. In: PAPPAGALLO M, ed. The neurological basis of pain. New York: McGraw-Hill, 2005:401-14.
96. SINDRUP SH, JENSEN TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002;18:22-7.
97. CAMPBELL FG, GRAHAM JG, ZILKHA KJ. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966;29:265-7.
98. JENSEN TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 2002;6(Suppl A):61-8.
99. KUTLUAY E, McCAGUE K, D'SOUZA J. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behavior 2003;4:175-80.
100. LIEBEL JT, MENGER N, LANGOHR H. Oxcarbazepine in der Behandlung der Trigeminus Neuralgie. Nervenheilkunde 2001;20:461-5.
101. BEYDOUN A. Safety and efficacy of oxcatbazepine: results of randomized, double-blind trials. Pharmacotherapy 2000;20:152S-158S.
102. ZAKRZEWSKA JM, CHAUDHRY Z, NURMIKKO TJ. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997;73:223-30.
103. FROMM GH, TERRENCE CF, CHATTHA AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984;15:240-4.
104. FROMM GH, TERRENCE CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 1987;37:1725-8.
105. LINDSTROM P, LINDBLOM U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 1987;28:45-50.
106. LECHIN F, van der DIJS B, LECHIN ME. Pimozide therapy for trigeminal neuralgia. Arch Neurol 1989;46:960-3.
107. KONDZIOLKA D, LEMLEY T, KESTLE JR. The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double blind placebo-controlled trial. J Neurosurg 1994;80:993-7.
108. EPSTEIN JB, MARCOE JH. Topical application of capsaicin fot treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994;77:135-40.
109. BENNETTO L, PTEL NK, FULLER G. Trigeminal neuralgia and its management. BMJ 2007;334:201-8.
110. FROMM GH, AUMENTADO D, TERRENCE CF. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain 1993;53:265-71.
111. NURMIKKO TJ, ELDRIDGE PR. Trigeminal neuralgia - pathophysiology, diagnosis and current treatment. Br J Anaesth 2001;87:117-32.
112. BOIVIE J. Central pain. In: MacMAHON SB, KOLTZEN-BURG M, eds. Wall and Melzack's textbook of pain. Oxford: Churchill Livingstone - Elsevier, 2005:1057-75.
113. ATTAL N, BOUHASSIRA D. Central neuropathic pain. In: PAPPAGALLO M, ed. The neurological basis of pain. New York: McGraw-Hill, 2005:301-19.
114. LEIJON G, BOIVIE J. Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
115. CARDENAS DD, WARMS CA, TURNER JA. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 2002;96:365-73.
116. VESTERGAARD K, ANDERSEN G, GOTTRUP H. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001;56:184-90.
117. FINNERUP NB, SINDRUP SH, BACH FW Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 2002;96:375-83.
118. LEVENDOGLU F, OGUN CO, OZERBIL O. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 2004;29:743-51.
119. DREWES AM, ANDREASEN A, POULSEN LH. Valproate for treatment of chronic central pain after spinal cord injury.A double-blind cross-over study. Paraplegia 1994;32:565-9.
120. CHIOU-TAN FY, TUEL SM, JOHNSON JC. Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehabil 1996;75:84-7.
121. SVENDSEN KB, JENSEN TS, BACH FW. The cannabinoid dronabinol reduces central pain in multiple sclerosis. A randomised double-blind placebo controlled cross-over trial. BMJ 2004;329:253-61.
122. ROG DJ, NURMIKKO TJ, FRIEDE T. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005;65:812-9.